# Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide

> **NCT03093090** · PHASE1 · WITHDRAWN · sponsor: **Yale University**

## Conditions studied

- Medication Absorption

## Interventions

- **DIETARY_SUPPLEMENT:** Water
- **DIETARY_SUPPLEMENT:** Parmalat™ Whole Milk
- **DIETARY_SUPPLEMENT:** Similac Pro-Advance™
- **DIETARY_SUPPLEMENT:** Ensure Plus™
- **DRUG:** Furosemide 20 MG

## Key facts

- **NCT ID:** NCT03093090
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-12-31
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never officially began
- **Last updated:** 2019-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03093090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03093090, "Evaluating Predictive Methods & Product Performance in Healthy Adults for Pediatric Patients, A Case Study: Furosemide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03093090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*